EDGAR Filing Documents for 0001193125-17-285465

Form SC 13D - General statement of acquisition of beneficial ownership:

SEC Accession No. 0001193125-17-285465

Filing Date

2017-09-15

Accepted

2017-09-14 20:58:06

Documents

Group Members

SOFTBANK VISION FUND L.P.SVF GP (JERSEY) LTDSVF HOLDINGS (UK) LLP

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D	d445331dsc13d.htm	SC 13D	90177
2	EXHIBIT 1	d445331dex991.htm	EX-99.1	11975
	Complete submission text file	0001193125-17-285465.txt		103878

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85963 | Film No.: 171086686
SIC: 2834 Pharmaceutical Preparations

Mailing Address 69 GROSVENOR STREET LONDON X0 W1K3JP

Business Address 69 GROSVENOR STREET LONDON X0 W1K3JP 6508435214

SVF Investments (UK) Ltd (Filed by) CIK: 0001716729 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D